ID   CSKP_HUMAN              Reviewed;         926 AA.
AC   O14936; A6NES1; B7ZKY0; O43215; Q17RI4; Q59HA0; Q5VT16; Q5VT17;
AC   Q5VT18; Q5VT19; Q66T42; Q9BYH6; Q9NYB2; Q9NYB3;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 3.
DT   10-MAY-2017, entry version 194.
DE   RecName: Full=Peripheral plasma membrane protein CASK;
DE            Short=hCASK;
DE            EC=2.7.11.1;
DE   AltName: Full=Calcium/calmodulin-dependent serine protein kinase;
DE   AltName: Full=Protein lin-2 homolog;
GN   Name=CASK; Synonyms=LIN2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND INTERACTION WITH SDC2 AND
RP   EPB41.
RC   TISSUE=Brain, Liver, and Lung;
RX   PubMed=9660868; DOI=10.1083/jcb.142.1.129;
RA   Cohen A.R., Woods D.F., Marfatia S.M., Walther Z., Chishti A.H.,
RA   Anderson J.M.;
RT   "Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to
RT   the basolateral membrane of epithelial cells.";
RL   J. Cell Biol. 142:129-138(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Zha D., Hu G.;
RT   "The human homolog of the rat CASK, Drosophila Camguk and C.elegans
RT   Lin-2 genes.";
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RC   TISSUE=Kidney;
RA   Ding L., Saijo K., Kawai K., Akaza H., Ugai H., Yokoyama K.K.,
RA   Ohno T.;
RT   "Putative alternative splicing form of human CASK mRNA (partial
RT   codes).";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Colon carcinoma;
RA   Yan Y., Merlin D.;
RT   "Caco2-BBE calcium/calmodulin-dependent serine protein kinase.";
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 5-926 (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 173-926 (ISOFORM 1), NUCLEOTIDE SEQUENCE
RP   [MRNA] OF 27-926 (ISOFORM 3), AND TISSUE SPECIFICITY.
RC   TISSUE=Fetus;
RX   PubMed=11003712; DOI=10.1007/s003350010170;
RA   Stevenson D., Laverty H.G., Wenwieser S., Douglas M., Wilson J.B.;
RT   "Mapping and expression analysis of the human CASK gene.";
RL   Mamm. Genome 11:934-937(2000).
RN   [9]
RP   INTERACTION WITH KIRREL3.
RX   PubMed=19012874; DOI=10.1016/j.ajhg.2008.10.020;
RA   Bhalla K., Luo Y., Buchan T., Beachem M.A., Guzauskas G.F., Ladd S.,
RA   Bratcher S.J., Schroer R.J., Balsamo J., DuPont B.R., Lilien J.,
RA   Srivastava A.K.;
RT   "Alterations in CDH15 and KIRREL3 in patients with mild to severe
RT   intellectual disability.";
RL   Am. J. Hum. Genet. 83:703-713(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-313, PHOSPHORYLATION
RP   [LARGE SCALE ANALYSIS] AT SER-571 (ISOFORM 3), PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-577 (ISOFORM 4), PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-192 (ISOFORM 5), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 489-572.
RX   PubMed=9546224; DOI=10.1038/nsb0498-317;
RA   Daniels D.L., Cohen A.R., Anderson J.M., Bruenger A.T.;
RT   "Crystal structure of the hCASK PDZ domain reveals the structural
RT   basis of class II PDZ domain target recognition.";
RL   Nat. Struct. Biol. 5:317-325(1998).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 1-337 IN COMPLEX WITH AMP,
RP   COFACTOR, ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   PHOSPHORYLATION OF NRXN1, AND PHOSPHORYLATION AT SER-151 AND SER-155.
RX   PubMed=18423203; DOI=10.1016/j.cell.2008.02.036;
RA   Mukherjee K., Sharma M., Urlaub H., Bourenkov G.P., Jahn R.,
RA   Suedhof T.C., Wahl M.C.;
RT   "CASK functions as a Mg2+-independent neurexin kinase.";
RL   Cell 133:328-339(2008).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-96.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [15]
RP   INVOLVEMENT IN MICPCH SYNDROME.
RX   PubMed=19165920; DOI=10.1038/ng.194;
RA   Najm J., Horn D., Wimplinger I., Golden J.A., Chizhikov V.V., Sudi J.,
RA   Christian S.L., Ullmann R., Kuechler A., Haas C.A., Flubacher A.,
RA   Charnas L.R., Uyanik G., Frank U., Klopocki E., Dobyns W.B.,
RA   Kutsche K.;
RT   "Mutations of CASK cause an X-linked brain malformation phenotype with
RT   microcephaly and hypoplasia of the brainstem and cerebellum.";
RL   Nat. Genet. 40:1065-1067(2008).
RN   [16]
RP   ERRATUM.
RA   Najm J., Horn D., Wimplinger I., Golden J.A., Chizhikov V.V., Sudi J.,
RA   Christian S.L., Ullmann R., Kuechler A., Haas C.A., Flubacher A.,
RA   Charnas L.R., Uyanik G., Frank U., Klopocki E., Dobyns W.B.,
RA   Kutsche K.;
RL   Nat. Genet. 40:1384-1384(2008).
RN   [17]
RP   VARIANT FGS4 LEU-28, AND CHARACTERIZATION OF VARIANT FGS4 LEU-28.
RX   PubMed=19200522; DOI=10.1016/j.ajhg.2008.12.018;
RA   Piluso G., D'Amico F., Saccone V., Bismuto E., Rotundo I.L.,
RA   Di Domenico M., Aurino S., Schwartz C.E., Neri G., Nigro V.;
RT   "A missense mutation in CASK causes FG syndrome in an Italian
RT   family.";
RL   Am. J. Hum. Genet. 84:162-177(2009).
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] MICPCH HIS-268; SER-396 AND GLY-710.
RX   PubMed=19377476; DOI=10.1038/ng.367;
RA   Tarpey P.S., Smith R., Pleasance E., Whibley A., Edkins S., Hardy C.,
RA   O'Meara S., Latimer C., Dicks E., Menzies A., Stephens P., Blow M.,
RA   Greenman C., Xue Y., Tyler-Smith C., Thompson D., Gray K., Andrews J.,
RA   Barthorpe S., Buck G., Cole J., Dunmore R., Jones D., Maddison M.,
RA   Mironenko T., Turner R., Turrell K., Varian J., West S., Widaa S.,
RA   Wray P., Teague J., Butler A., Jenkinson A., Jia M., Richardson D.,
RA   Shepherd R., Wooster R., Tejada M.I., Martinez F., Carvill G.,
RA   Goliath R., de Brouwer A.P., van Bokhoven H., Van Esch H., Chelly J.,
RA   Raynaud M., Ropers H.H., Abidi F.E., Srivastava A.K., Cox J., Luo Y.,
RA   Mallya U., Moon J., Parnau J., Mohammed S., Tolmie J.L.,
RA   Shoubridge C., Corbett M., Gardner A., Haan E., Rujirabanjerd S.,
RA   Shaw M., Vandeleur L., Fullston T., Easton D.F., Boyle J.,
RA   Partington M., Hackett A., Field M., Skinner C., Stevenson R.E.,
RA   Bobrow M., Turner G., Schwartz C.E., Gecz J., Raymond F.L.,
RA   Futreal P.A., Stratton M.R.;
RT   "A systematic, large-scale resequencing screen of X-chromosome coding
RT   exons in mental retardation.";
RL   Nat. Genet. 41:535-543(2009).
CC   -!- FUNCTION: Multidomain scaffolding protein with a role in synaptic
CC       transmembrane protein anchoring and ion channel trafficking.
CC       Contributes to neural development and regulation of gene
CC       expression via interaction with the transcription factor TBR1.
CC       Binds to cell-surface proteins, including amyloid precursor
CC       protein, neurexins and syndecans. May mediate a link between the
CC       extracellular matrix and the actin cytoskeleton via its
CC       interaction with syndecan and with the actin/spectrin-binding
CC       protein 4.1.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Note=Unlike other protein kinases, does not require a divalent
CC       cation such as magnesium for catalytic activity.
CC       {ECO:0000269|PubMed:18423203};
CC   -!- ENZYME REGULATION: Differs from archetypal CaMK members in that
CC       the kinase domain exhibits a constitutively active conformation
CC       and the autoinhibitory region does not engage in direct contact
CC       with the ATP-binding cleft, although it still binds Ca(2+)/CAM.
CC       {ECO:0000269|PubMed:18423203}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=563 uM for ATP {ECO:0000269|PubMed:18423203};
CC         Note=Kinetics of autophosphorylation assay were measured, rather
CC         than phosphorylation of an exogenous substrate.;
CC   -!- SUBUNIT: Binds WHRN and NRXN1 cytosolic tail. Interacts with
CC       CASKIN1, APBA1, LIN7(A/B/C) and L27 domain of DLG1 and isoform 2
CC       of DLG4 (By similarity). CASK and LIN7 form two mutually exclusive
CC       tripartite complexes with APBA1 or CASKIN1 (By similarity).
CC       Interacts with FCHSD2. Interacts with TSPYL2. Part of a complex
CC       containing CASK, TBR1 and TSPYL2 (By similarity). Identified in a
CC       complex with ACTN4, IQGAP1, MAGI2, NPHS1, SPTAN1 and SPTBN1 (By
CC       similarity). Interacts with KIRREL3. {ECO:0000250,
CC       ECO:0000269|PubMed:18423203, ECO:0000269|PubMed:19012874,
CC       ECO:0000269|PubMed:9660868}.
CC   -!- INTERACTION:
CC       Q8WXD9:CASKIN1; NbExp=4; IntAct=EBI-1215506, EBI-970261;
CC       Q12929:EPS8; NbExp=3; IntAct=EBI-1215506, EBI-375576;
CC       P41134:ID1; NbExp=3; IntAct=EBI-1215506, EBI-1215527;
CC       O14910:LIN7A; NbExp=6; IntAct=EBI-1215506, EBI-2513988;
CC       Q63373:Nrxn1 (xeno); NbExp=3; IntAct=EBI-1215506, EBI-1780696;
CC       Q9Y2J0:RPH3A; NbExp=3; IntAct=EBI-1215506, EBI-1216802;
CC       P34741:SDC2; NbExp=2; IntAct=EBI-1215506, EBI-1172957;
CC       Q9H788:SH2D4A; NbExp=3; IntAct=EBI-1215506, EBI-747035;
CC       Q13425:SNTB2; NbExp=2; IntAct=EBI-1215506, EBI-80411;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm
CC       {ECO:0000250}. Cell membrane {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=O14936-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14936-2; Sequence=VSP_024426;
CC       Name=3;
CC         IsoId=O14936-3; Sequence=VSP_024422, VSP_024424;
CC         Note=Contains a phosphoserine at position 571.
CC         {ECO:0000244|PubMed:24275569};
CC       Name=4;
CC         IsoId=O14936-4; Sequence=VSP_024424, VSP_024426;
CC         Note=Contains a phosphoserine at position 577.
CC         {ECO:0000244|PubMed:24275569};
CC       Name=5;
CC         IsoId=O14936-5; Sequence=VSP_024421, VSP_024423, VSP_024424;
CC         Note=Contains a phosphoserine at position 192.
CC         {ECO:0000244|PubMed:24275569};
CC       Name=6;
CC         IsoId=O14936-6; Sequence=VSP_024425, VSP_024426;
CC         Note=Gene prediction confirmed by EST data.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Expression is significantly
CC       greater in brain relative to kidney, lung, and liver and in fetal
CC       brain and kidney relative to lung and liver.
CC       {ECO:0000269|PubMed:11003712}.
CC   -!- DOMAIN: The first L27 domain binds DLG1 and the second L27 domain
CC       probably binds LIN7. {ECO:0000250}.
CC   -!- DOMAIN: The protein kinase domain mediates the interaction with
CC       FCHSD2.
CC   -!- DISEASE: Mental retardation and microcephaly with pontine and
CC       cerebellar hypoplasia (MICPCH) [MIM:300749]: A disorder
CC       characterized by significantly below average general intellectual
CC       functioning associated with impairments in adaptive behavior and
CC       manifested during the developmental period. Affected individuals
CC       can manifest a severe phenotype consisting of severe intellectual
CC       deficit, congenital or postnatal microcephaly, disproportionate
CC       brainstem and cerebellar hypoplasia. A milder phenotype consists
CC       of mental retardation alone or associated with nystagmus.
CC       {ECO:0000269|PubMed:19165920, ECO:0000269|PubMed:19377476}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: FG syndrome 4 (FGS4) [MIM:300422]: FG syndrome (FGS) is
CC       an X-linked disorder characterized by mental retardation, relative
CC       macrocephaly, hypotonia and constipation.
CC       {ECO:0000269|PubMed:19200522}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the protein
CC       kinase superfamily. CAMK Ser/Thr protein kinase family. CaMK
CC       subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the MAGUK family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF032119; AAB88125.1; -; mRNA.
DR   EMBL; AF035582; AAB88198.1; -; mRNA.
DR   EMBL; AB039327; BAB12252.2; -; mRNA.
DR   EMBL; AY705392; AAU10527.1; -; mRNA.
DR   EMBL; AL627402; CAH71237.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAH71237.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAH71237.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAH71237.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAH71237.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAH71238.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAH71238.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAH71238.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAH71238.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAH71238.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAH71239.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAH71239.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAH71239.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAH71239.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAH71239.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAH71240.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAH71240.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAH71240.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAH71240.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAH71240.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI41092.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAI41092.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAI41092.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI41092.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI41092.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI41093.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAI41093.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAI41093.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI41093.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI41093.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI41094.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAI41094.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAI41094.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI41094.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI41094.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI41095.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAI41095.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAI41095.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI41095.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI41095.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI41634.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAI41634.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAI41634.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI41634.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI41634.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI41635.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAI41635.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAI41635.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI41635.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI41635.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI41636.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAI41636.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAI41636.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI41636.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI41636.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI41637.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAI41637.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAI41637.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI41637.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI41637.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAI42244.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAI42244.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI42244.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI42244.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI42244.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAI42245.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAI42245.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI42245.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI42245.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI42245.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAI42246.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAI42246.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI42246.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI42246.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI42246.1; JOINED; Genomic_DNA.
DR   EMBL; AL353691; CAI42247.1; -; Genomic_DNA.
DR   EMBL; AL158144; CAI42247.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI42247.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI42247.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI42247.1; JOINED; Genomic_DNA.
DR   EMBL; AL158144; CAI42762.1; -; Genomic_DNA.
DR   EMBL; AL353691; CAI42762.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI42762.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI42762.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI42762.1; JOINED; Genomic_DNA.
DR   EMBL; AL158144; CAI42763.1; -; Genomic_DNA.
DR   EMBL; AL353691; CAI42763.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI42763.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI42763.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI42763.1; JOINED; Genomic_DNA.
DR   EMBL; AL158144; CAI42764.1; -; Genomic_DNA.
DR   EMBL; AL353691; CAI42764.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI42764.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI42764.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI42764.1; JOINED; Genomic_DNA.
DR   EMBL; AL158144; CAI42765.1; -; Genomic_DNA.
DR   EMBL; AL353691; CAI42765.1; JOINED; Genomic_DNA.
DR   EMBL; AL445239; CAI42765.1; JOINED; Genomic_DNA.
DR   EMBL; AL603754; CAI42765.1; JOINED; Genomic_DNA.
DR   EMBL; AL627402; CAI42765.1; JOINED; Genomic_DNA.
DR   EMBL; BC117311; AAI17312.1; -; mRNA.
DR   EMBL; BC143454; AAI43455.1; -; mRNA.
DR   EMBL; AB208859; BAD92096.1; -; mRNA.
DR   EMBL; AF262404; AAF72666.1; -; mRNA.
DR   EMBL; AF262405; AAF72667.1; -; mRNA.
DR   CCDS; CCDS14257.1; -. [O14936-2]
DR   CCDS; CCDS48094.1; -. [O14936-3]
DR   CCDS; CCDS48095.1; -. [O14936-4]
DR   RefSeq; NP_001119526.1; NM_001126054.2. [O14936-4]
DR   RefSeq; NP_001119527.1; NM_001126055.2. [O14936-3]
DR   RefSeq; NP_003679.2; NM_003688.3. [O14936-2]
DR   UniGene; Hs.495984; -.
DR   PDB; 1KGD; X-ray; 1.31 A; A=739-914.
DR   PDB; 1KWA; X-ray; 1.93 A; A/B=487-572.
DR   PDB; 1ZL8; NMR; -; B=403-456.
DR   PDB; 3C0G; X-ray; 2.19 A; A/B=1-337.
DR   PDB; 3C0H; X-ray; 2.30 A; A/B=1-337.
DR   PDB; 3C0I; X-ray; 1.85 A; A=1-337.
DR   PDB; 3MFR; X-ray; 2.00 A; A=1-337.
DR   PDB; 3MFS; X-ray; 2.10 A; A=1-337.
DR   PDB; 3MFT; X-ray; 2.20 A; A=1-337.
DR   PDB; 3MFU; X-ray; 2.30 A; A=1-337.
DR   PDB; 3TAC; X-ray; 2.20 A; A=1-345.
DR   PDBsum; 1KGD; -.
DR   PDBsum; 1KWA; -.
DR   PDBsum; 1ZL8; -.
DR   PDBsum; 3C0G; -.
DR   PDBsum; 3C0H; -.
DR   PDBsum; 3C0I; -.
DR   PDBsum; 3MFR; -.
DR   PDBsum; 3MFS; -.
DR   PDBsum; 3MFT; -.
DR   PDBsum; 3MFU; -.
DR   PDBsum; 3TAC; -.
DR   ProteinModelPortal; O14936; -.
DR   SMR; O14936; -.
DR   BioGrid; 114141; 71.
DR   DIP; DIP-38727N; -.
DR   IntAct; O14936; 49.
DR   MINT; MINT-102444; -.
DR   STRING; 9606.ENSP00000367408; -.
DR   BindingDB; O14936; -.
DR   ChEMBL; CHEMBL1908381; -.
DR   DrugBank; DB01942; Formic Acid.
DR   GuidetoPHARMACOLOGY; 1959; -.
DR   iPTMnet; O14936; -.
DR   PhosphoSitePlus; O14936; -.
DR   BioMuta; CASK; -.
DR   EPD; O14936; -.
DR   MaxQB; O14936; -.
DR   PaxDb; O14936; -.
DR   PeptideAtlas; O14936; -.
DR   PRIDE; O14936; -.
DR   TopDownProteomics; O14936-5; -. [O14936-5]
DR   DNASU; 8573; -.
DR   Ensembl; ENST00000378158; ENSP00000367400; ENSG00000147044. [O14936-6]
DR   Ensembl; ENST00000378163; ENSP00000367405; ENSG00000147044. [O14936-1]
DR   Ensembl; ENST00000378166; ENSP00000367408; ENSG00000147044. [O14936-2]
DR   Ensembl; ENST00000421587; ENSP00000400526; ENSG00000147044. [O14936-3]
DR   Ensembl; ENST00000442742; ENSP00000398007; ENSG00000147044. [O14936-4]
DR   GeneID; 8573; -.
DR   KEGG; hsa:8573; -.
DR   UCSC; uc004dfl.5; human. [O14936-1]
DR   CTD; 8573; -.
DR   DisGeNET; 8573; -.
DR   GeneCards; CASK; -.
DR   GeneReviews; CASK; -.
DR   HGNC; HGNC:1497; CASK.
DR   HPA; CAB001949; -.
DR   HPA; HPA023857; -.
DR   MalaCards; CASK; -.
DR   MIM; 300172; gene.
DR   MIM; 300422; phenotype.
DR   MIM; 300749; phenotype.
DR   neXtProt; NX_O14936; -.
DR   OpenTargets; ENSG00000147044; -.
DR   Orphanet; 1934; Early infantile epileptic encephalopathy.
DR   Orphanet; 323; FG syndrome.
DR   Orphanet; 163937; X-linked intellectual disability, Najm type.
DR   PharmGKB; PA26081; -.
DR   eggNOG; KOG0033; Eukaryota.
DR   eggNOG; KOG0609; Eukaryota.
DR   eggNOG; COG0194; LUCA.
DR   GeneTree; ENSGT00760000118866; -.
DR   HOVERGEN; HBG001858; -.
DR   InParanoid; O14936; -.
DR   KO; K06103; -.
DR   OMA; LVCTASQ; -.
DR   OrthoDB; EOG091G065I; -.
DR   PhylomeDB; O14936; -.
DR   TreeFam; TF314263; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   BRENDA; 2.7.4.8; 2681.
DR   Reactome; R-HSA-212676; Dopamine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-373753; Nephrin interactions.
DR   Reactome; R-HSA-6794361; Interactions of neurexins and neuroligins at synapses.
DR   SignaLink; O14936; -.
DR   SIGNOR; O14936; -.
DR   ChiTaRS; CASK; human.
DR   EvolutionaryTrace; O14936; -.
DR   GeneWiki; CASK; -.
DR   GenomeRNAi; 8573; -.
DR   PRO; PR:O14936; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000147044; -.
DR   CleanEx; HS_CASK; -.
DR   ExpressionAtlas; O14936; baseline and differential.
DR   Genevisible; O14936; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005604; C:basement membrane; IDA:CACAO.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0005911; C:cell-cell junction; IDA:BHF-UCL.
DR   GO; GO:0060170; C:ciliary membrane; ISS:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005652; C:nuclear lamina; IDA:BHF-UCL.
DR   GO; GO:0016363; C:nuclear matrix; IDA:BHF-UCL.
DR   GO; GO:0005730; C:nucleolus; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:ProtInc.
DR   GO; GO:0042734; C:presynaptic membrane; ISS:BHF-UCL.
DR   GO; GO:0031982; C:vesicle; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004385; F:guanylate kinase activity; TAS:ProtInc.
DR   GO; GO:0042043; F:neurexin family protein binding; IEA:Ensembl.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0070509; P:calcium ion import; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0001953; P:negative regulation of cell-matrix adhesion; IMP:BHF-UCL.
DR   GO; GO:0090288; P:negative regulation of cellular response to growth factor stimulus; IMP:BHF-UCL.
DR   GO; GO:0010839; P:negative regulation of keratinocyte proliferation; IDA:CACAO.
DR   GO; GO:0061045; P:negative regulation of wound healing; IMP:BHF-UCL.
DR   GO; GO:0007269; P:neurotransmitter secretion; TAS:Reactome.
DR   GO; GO:0090280; P:positive regulation of calcium ion import; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   Gene3D; 1.10.287.650; -; 2.
DR   InterPro; IPR008145; GK/Ca_channel_bsu.
DR   InterPro; IPR008144; Guanylate_kin-like_dom.
DR   InterPro; IPR020590; Guanylate_kinase_CS.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR014775; L27_C.
DR   InterPro; IPR004172; L27_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR011511; SH3_2.
DR   InterPro; IPR001452; SH3_domain.
DR   Pfam; PF00625; Guanylate_kin; 1.
DR   Pfam; PF02828; L27; 2.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF07653; SH3_2; 1.
DR   SMART; SM00072; GuKc; 1.
DR   SMART; SM00569; L27; 2.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF101288; SSF101288; 2.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00856; GUANYLATE_KINASE_1; 1.
DR   PROSITE; PS50052; GUANYLATE_KINASE_2; 1.
DR   PROSITE; PS51022; L27; 2.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Calmodulin-binding;
KW   Cell membrane; Complete proteome; Cytoplasm; Disease mutation; Kinase;
KW   Membrane; Mental retardation; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; SH3 domain; Transferase.
FT   CHAIN         1    926       Peripheral plasma membrane protein CASK.
FT                                /FTId=PRO_0000094568.
FT   DOMAIN       12    276       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      343    398       L27 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00365}.
FT   DOMAIN      402    455       L27 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00365}.
FT   DOMAIN      489    564       PDZ. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00143}.
FT   DOMAIN      615    682       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      739    911       Guanylate kinase-like.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00100}.
FT   NP_BIND      18     26       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00100, ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      305    315       Calmodulin-binding.
FT   ACT_SITE    141    141       {ECO:0000250}.
FT   BINDING      41     41       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      51     51       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     151    151       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:18423203}.
FT   MOD_RES     155    155       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:18423203}.
FT   MOD_RES     182    182       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O70589}.
FT   MOD_RES     313    313       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1    385       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_024421.
FT   VAR_SEQ     340    345       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11003712,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_024422.
FT   VAR_SEQ     386    386       L -> M (in isoform 5).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_024423.
FT   VAR_SEQ     580    602       Missing (in isoform 3, isoform 4 and
FT                                isoform 5). {ECO:0000303|PubMed:11003712,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2, ECO:0000303|Ref.3}.
FT                                /FTId=VSP_024424.
FT   VAR_SEQ     603    614       Missing (in isoform 6). {ECO:0000305}.
FT                                /FTId=VSP_024425.
FT   VAR_SEQ     719    723       Missing (in isoform 2, isoform 4 and
FT                                isoform 6). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9660868,
FT                                ECO:0000303|Ref.4, ECO:0000303|Ref.7}.
FT                                /FTId=VSP_024426.
FT   VARIANT      28     28       R -> L (in FGS4; does not reveal
FT                                significant alterations induced by the
FT                                mutation substitution; causes a partial
FT                                skipping of exon 2 of the protein;
FT                                dbSNP:rs137852816).
FT                                {ECO:0000269|PubMed:19200522}.
FT                                /FTId=VAR_058719.
FT   VARIANT      96     96       G -> V (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041956.
FT   VARIANT     268    268       Y -> H (in MICPCH; dbSNP:rs137852817).
FT                                {ECO:0000269|PubMed:19377476}.
FT                                /FTId=VAR_062996.
FT   VARIANT     396    396       P -> S (in MICPCH; dbSNP:rs137852820).
FT                                {ECO:0000269|PubMed:19377476}.
FT                                /FTId=VAR_062997.
FT   VARIANT     710    710       D -> G (in MICPCH; dbSNP:rs137852818).
FT                                {ECO:0000269|PubMed:19377476}.
FT                                /FTId=VAR_062998.
FT   CONFLICT    401    401       P -> L (in Ref. 2; AAB88198).
FT                                {ECO:0000305}.
FT   CONFLICT    479    479       D -> G (in Ref. 1; AAB88125, 3; BAB12252,
FT                                4; AAU10527 and 8; AAF72666/AAF72667).
FT                                {ECO:0000305}.
FT   CONFLICT    675    675       P -> S (in Ref. 1; AAB88125 and 4;
FT                                AAU10527). {ECO:0000305}.
FT   CONFLICT    780    780       K -> R (in Ref. 1; AAB88125 and 4;
FT                                AAU10527). {ECO:0000305}.
FT   HELIX         8     11       {ECO:0000244|PDB:3C0I}.
FT   STRAND       12     20       {ECO:0000244|PDB:3C0I}.
FT   STRAND       22     31       {ECO:0000244|PDB:3C0I}.
FT   TURN         32     34       {ECO:0000244|PDB:3C0I}.
FT   STRAND       37     44       {ECO:0000244|PDB:3C0I}.
FT   HELIX        45     49       {ECO:0000244|PDB:3C0I}.
FT   STRAND       51     53       {ECO:0000244|PDB:3C0I}.
FT   HELIX        56     68       {ECO:0000244|PDB:3C0I}.
FT   STRAND       77     83       {ECO:0000244|PDB:3C0I}.
FT   STRAND       86     92       {ECO:0000244|PDB:3C0I}.
FT   HELIX        99    108       {ECO:0000244|PDB:3C0I}.
FT   HELIX       115    134       {ECO:0000244|PDB:3C0I}.
FT   HELIX       144    146       {ECO:0000244|PDB:3C0I}.
FT   STRAND      147    149       {ECO:0000244|PDB:3C0I}.
FT   STRAND      151    153       {ECO:0000244|PDB:3C0I}.
FT   STRAND      158    160       {ECO:0000244|PDB:3C0I}.
FT   HELIX       163    165       {ECO:0000244|PDB:3TAC}.
FT   STRAND      171    173       {ECO:0000244|PDB:3MFS}.
FT   HELIX       183    185       {ECO:0000244|PDB:3C0I}.
FT   HELIX       188    191       {ECO:0000244|PDB:3C0I}.
FT   HELIX       199    214       {ECO:0000244|PDB:3C0I}.
FT   HELIX       223    232       {ECO:0000244|PDB:3C0I}.
FT   HELIX       239    242       {ECO:0000244|PDB:3C0I}.
FT   HELIX       247    256       {ECO:0000244|PDB:3C0I}.
FT   TURN        261    263       {ECO:0000244|PDB:3C0I}.
FT   HELIX       267    271       {ECO:0000244|PDB:3C0I}.
FT   HELIX       274    277       {ECO:0000244|PDB:3C0I}.
FT   HELIX       279    282       {ECO:0000244|PDB:3C0I}.
FT   HELIX       289    302       {ECO:0000244|PDB:3C0I}.
FT   TURN        304    306       {ECO:0000244|PDB:3TAC}.
FT   HELIX       309    312       {ECO:0000244|PDB:3C0G}.
FT   STRAND      314    316       {ECO:0000244|PDB:3C0G}.
FT   HELIX       404    416       {ECO:0000244|PDB:1ZL8}.
FT   HELIX       423    431       {ECO:0000244|PDB:1ZL8}.
FT   HELIX       437    450       {ECO:0000244|PDB:1ZL8}.
FT   STRAND      489    495       {ECO:0000244|PDB:1KWA}.
FT   STRAND      497    499       {ECO:0000244|PDB:1KWA}.
FT   STRAND      503    506       {ECO:0000244|PDB:1KWA}.
FT   HELIX       510    512       {ECO:0000244|PDB:1KWA}.
FT   STRAND      513    518       {ECO:0000244|PDB:1KWA}.
FT   HELIX       523    527       {ECO:0000244|PDB:1KWA}.
FT   STRAND      535    539       {ECO:0000244|PDB:1KWA}.
FT   HELIX       544    546       {ECO:0000244|PDB:1KWA}.
FT   HELIX       549    558       {ECO:0000244|PDB:1KWA}.
FT   STRAND      561    568       {ECO:0000244|PDB:1KWA}.
FT   STRAND      741    745       {ECO:0000244|PDB:1KGD}.
FT   HELIX       752    762       {ECO:0000244|PDB:1KGD}.
FT   TURN        764    766       {ECO:0000244|PDB:1KGD}.
FT   TURN        784    786       {ECO:0000244|PDB:1KGD}.
FT   HELIX       793    801       {ECO:0000244|PDB:1KGD}.
FT   STRAND      805    811       {ECO:0000244|PDB:1KGD}.
FT   STRAND      814    819       {ECO:0000244|PDB:1KGD}.
FT   HELIX       820    828       {ECO:0000244|PDB:1KGD}.
FT   STRAND      832    836       {ECO:0000244|PDB:1KGD}.
FT   HELIX       839    841       {ECO:0000244|PDB:1KGD}.
FT   HELIX       842    845       {ECO:0000244|PDB:1KGD}.
FT   TURN        848    850       {ECO:0000244|PDB:1KGD}.
FT   STRAND      852    858       {ECO:0000244|PDB:1KGD}.
FT   HELIX       870    886       {ECO:0000244|PDB:1KGD}.
FT   HELIX       887    889       {ECO:0000244|PDB:1KGD}.
FT   STRAND      891    895       {ECO:0000244|PDB:1KGD}.
FT   HELIX       899    913       {ECO:0000244|PDB:1KGD}.
SQ   SEQUENCE   926 AA;  105123 MW;  6C02008CE52728BA CRC64;
     MADDDVLFED VYELCEVIGK GPFSVVRRCI NRETGQQFAV KIVDVAKFTS SPGLSTEDLK
     REASICHMLK HPHIVELLET YSSDGMLYMV FEFMDGADLC FEIVKRADAG FVYSEAVASH
     YMRQILEALR YCHDNNIIHR DVKPHCVLLA SKENSAPVKL GGFGVAIQLG ESGLVAGGRV
     GTPHFMAPEV VKREPYGKPV DVWGCGVILF ILLSGCLPFY GTKERLFEGI IKGKYKMNPR
     QWSHISESAK DLVRRMLMLD PAERITVYEA LNHPWLKERD RYAYKIHLPE TVEQLRKFNA
     RRKLKGAVLA AVSSHKFNSF YGDPPEELPD FSEDPTSSGL LAAERAVSQV LDSLEEIHAL
     TDCSEKDLDF LHSVFQDQHL HTLLDLYDKI NTKSSPQIRN PPSDAVQRAK EVLEEISCYP
     ENNDAKELKR ILTQPHFMAL LQTHDVVAHE VYSDEALRVT PPPTSPYLNG DSPESANGDM
     DMENVTRVRL VQFQKNTDEP MGITLKMNEL NHCIVARIMH GGMIHRQGTL HVGDEIREIN
     GISVANQTVE QLQKMLREMR GSITFKIVPS YRTQSSSCER DSPSTSRQSP ANGHSSTNNS
     VSDLPSTTQP KGRQIYVRAQ FEYDPAKDDL IPCKEAGIRF RVGDIIQIIS KDDHNWWQGK
     LENSKNGTAG LIPSPELQEW RVACIAMEKT KQEQQASCTW FGKKKKQYKD KYLAKHNAVF
     DQLDLVTYEE VVKLPAFKRK TLVLLGAHGV GRRHIKNTLI TKHPDRFAYP IPHTTRPPKK
     DEENGKNYYF VSHDQMMQDI SNNEYLEYGS HEDAMYGTKL ETIRKIHEQG LIAILDVEPQ
     ALKVLRTAEF APFVVFIAAP TITPGLNEDE SLQRLQKESD ILQRTYAHYF DLTIINNEID
     ETIRHLEEAV ELVCTAPQWV PVSWVY
//
